Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer's disease (AD) and other ...
My report from the Legislature last week mentioned that we may have hit the accelerator a bit too hard on the bridge and road (infrastructure) naming process. Continuing that allegory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results